CELGENE CORP /DE/
10-Q, EX-27, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CELGENE CORP /DE/, 10-Q, 2000-08-14
Next: JB OXFORD HOLDINGS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                                       0000816284
<NAME>                             CELGENE CORPORATION
<MULTIPLIER>                                     1,000
<CURRENCY>                                  US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             MAR-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                     122,450,487
<SECURITIES>                               169,498,195
<RECEIVABLES>                                8,553,608
<ALLOWANCES>                                   296,601
<INVENTORY>                                  3,144,485
<CURRENT-ASSETS>                           318,386,205
<PP&E>                                      12,263,668
<DEPRECIATION>                              (9,183,583)
<TOTAL-ASSETS>                             325,165,309
<CURRENT-LIABILITIES>                       22,070,128
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       657,366
<OTHER-SE>                                 276,112,547
<TOTAL-LIABILITY-AND-EQUITY>               276,769,913
<SALES>                                     27,875,220
<TOTAL-REVENUES>                            28,884,836
<CGS>                                        4,221,420
<TOTAL-COSTS>                               38,515,121
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,437,086
<INCOME-PRETAX>                             (3,971,178)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (3,971,178)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (3,971,178)
<EPS-BASIC>                                      (0.06)
<EPS-DILUTED>                                    (0.06)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission